Augmenting Function for Infarction from Infection: Impella 2.5 for Ischemic Cardiogenic Shock Complicating Sepsis.

about

Augmenting Function for Infarction from Infection: Impella 2.5 for Ischemic Cardiogenic Shock Complicating Sepsis.

Item

http://www.wikidata.org/entity/Q40307638

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Augmenting Function for Infarc ...... nic Shock Complicating Sepsis.

@en

type

Item

label

Augmenting Function for Infarc ...... nic Shock Complicating Sepsis.

@en

prefLabel

Augmenting Function for Infarc ...... nic Shock Complicating Sepsis.

@en

P1476

Augmenting Function for Infarc ...... enic Shock Complicating Sepsis

@en

P2093

Anuj Gupta

http://www.w3.org/2001/XMLSchema#string

Michael T McCurdy

http://www.w3.org/2001/XMLSchema#string

Mukta C Srivastava

http://www.w3.org/2001/XMLSchema#string

Robert M Reed

http://www.w3.org/2001/XMLSchema#string

Semhar Z Tewelde

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized trial of protocol-based care for early septic shock

Prevalence of coronary heart disease--United States, 2006-2010.

A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.

Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.

Causes of death and determinants of outcome in critically ill patients.

Survival after shock requiring high-dose vasopressor therapy

Novel percutaneous cardiac assist devices: the science of and indications for hemodynamic support.

Mechanical circulatory support devices in the ICU.

A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.

Does timing of post-renal transplant diuresis affect graft survival in live-donor renal transplants?

P304

8407530

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1155/2017/8407530

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Praveen George

Jonathan Ludmir

P577

2017-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28261505

http://www.w3.org/2001/XMLSchema#string

P921

cardiogenic shock

P932

5316439

http://www.w3.org/2001/XMLSchema#string